Hypomethylation and apoptosis in 5-azacytidine–treated myeloid cells-Reference-Cited by-同舟云学术

Hypomethylation and apoptosis in 5-azacytidine–treated myeloid cells

Published:2008-02 Issue:2 Volume:36 Page:149-157
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Khan Rasheed,Schmidt-Mende Jan,Karimi Mohsen,Gogvadze Vladimir,Hassan Moustapha,Ekström Tomas J.,Zhivotovsky Boris,Hellström-Lindberg Eva

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference47 articles.

1. Treatment of myelodysplastic syndromes with 5-azacytidine;Gryn;Leuk Res,2002

2. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes;Silverman;Leukemia,1993

3. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B;Silverman;J Clin Oncol,2002

4. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study;Kornblith;J Clin Oncol,2002

5. Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions;Notari;J Pharm Sci,1975

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Changes in the HTR8 and 3A-sub E placental Cell Lines Exposed to Bisphenol A and Benzyl Butyl Phthalate;Toxics;2024-09-09

2. Clinical Response to Azacitidine in Myelodysplastic Neoplasms is Associated with Distinct DNA Methylation Changes in Haematopoietic Stem and Progenitor cellsin vivo;2024-07-23

3. Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis;PLOS ONE;2023-09-08

4. Anti-CD47 antibodies: A potential new cancer immunotherapy;Journal of Cancer Research and Practice;2023

5. High-Risk Acute Myeloid Leukemia: A Pediatric Prospective;Biomedicines;2022-06-14